scholarly article | Q13442814 |
editorial | Q871232 |
P356 | DOI | 10.1038/NCPRHEUM0806 |
P698 | PubMed publication ID | 18431369 |
P2093 | author name string | Michael H Weisman | |
P2860 | cites work | Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial | Q34651182 |
Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial) | Q36204088 | ||
Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis | Q37007690 | ||
The widening mortality gap between rheumatoid arthritis patients and the general population | Q38459919 | ||
COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention | Q43882911 | ||
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial | Q44985061 | ||
Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: A double-blind, randomized, placebo-controlled trial | Q58234944 | ||
Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis | Q73573994 | ||
Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial | Q79984440 | ||
Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis | Q80544699 | ||
P433 | issue | 6 | |
P921 | main subject | rheumatoid arthritis | Q187255 |
P304 | page(s) | 298-299 | |
P577 | publication date | 2008-04-22 | |
P1433 | published in | Nature Clinical Practice Rheumatology | Q15752269 |
P1476 | title | Do all drugs and treatments for rheumatoid arthritis have the same efficacy? | |
P478 | volume | 4 |
Q34081871 | Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis. |
Q36980842 | Vaccination with endosomal unknown epitopes produces therapeutic response in rheumatoid arthritis patients and modulates adjuvant arthritis of rats. |
Search more.